Safyral is a brand name for the drug drospirenone. Safyral is an oral contraceptive that contains estrogen, Ethinyl estradiol, and drospirenone. Safyral drug was approved by Food and Drug Administration in USA on September 2010. Safyral is used as a contraceptive and also to lower the risk of fetal neural tube defect.
Safyral is a combination of three drugs namely drospirenone, ethynyl estradiol, and levomefolate. Each drug has its own purpose making Safyral effective in its functions. Drospirenone and ethynyl estradiol is used to inhibit the release of the egg from the ovary for fertilization to take place. It is able to accomplish this by changing the biological functions of the uterine wall. On the other hand, levomefolate is used to prevent rare birth defects when giving birth.
When the three drugs are combined, they form Safyral whose purpose is to prevent pregnancy and also increase the folate levels in women who opt to use the birth pills as a way of preventing pregnancy.